Join to view full profile
Bristol-Myers SquibbRoute 206 and Provinceline RoadPrinceton, NJ 08540
Phone+1 609-252-3244
Dr. Birkhofer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Medical CollegeClass of 1983
Publications & Presentations
PubMed
- 47 citationsA Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult MenDiptee A. Gajjar, Frank LaCreta, Howard Uderman, Georgia Kollia, Glenn F. Duncan
Pharmacotherapy. 2000-06-01 - 455 citationsCTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgarisJudith R. Abrams, Mark Lebwohl, Cynthia Guzzo, Brian V. Jegasothy, Michael T. Goldfarb
The Journal of Clinical Investigation. 1999-05-01 - 16 citationsBioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancerNeal J. Meropol, Daryl S. Sonnichsen, Martin J. Birkhofer, Irene Ferreira, D Noel
Cancer Chemotherapy and Pharmacology. 1999-01-01
Press Mentions
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (Trifluridine and Tipiracil) Published in JAMA OncologyOctober 10th, 2019
Taiho Oncology and Servier Present LONSURF® (Trifluridine and Tipiracil) Data at the 2019 ASCO Annual MeetingJune 3rd, 2019
NCCN Awards Grants to Investigators to Study Trifluridine and Tipiracil in Various CancersMarch 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
